The effect of catecholamines and adrenergic blocking agents on the calcium and glycogen content in the rat heart.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D002395:Catecholamines / Q000494:pharmacology*; D004873:Ergolines / Q000494:pharmacology; D006003:Glycogen / Q000378:metabolism*; D006321:Heart / Q000187:drug effects*; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D004873:Ergolines; D010643:Phenoxybenzamine; D006003:Glycogen; D011433:Propranolol; D002118:Calcium